drugset / Trial / NCT03927677
The Effect of Colchicine on the Pharmacokinetic Profile of LC350189 in Healthy Aldults.
SequentialOpen-labelTreatment
Summary
This is a Phase 1, open-label, fixed-sequence, 3-period, 2-way drug interaction study designed to assess the PK, PD, safety, and tolerability of LC350189 and colchicine when administered alone and in combination in healthy subjects.
Timeline
- Start
- 2019-11-05
- Primary completion
- 2019-11-26
- Completion
- 2019-11-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tigulixostat | Small molecule | 200 mg | — |